A rise in all-cause mortality in China following termination of the Zero COVID Policy

After China abandoned its zero COVID policy in December 2022, a significant surge in excess deaths occurred, totaling an estimated 1.87 million within two months. The figures starkly surpassed China’s official estimate of 60,000 COVID-19 deaths, pointing to the potential impact of limited immunity in the population.

3 Steps to Unlock the True Potential of AI for Health Leaders

Robbie Hughes, founder and CEO, Lumeon The AI buzz is not subsiding, making headlines across industries. In his summary article about the 2024 HIMSS conference,

May 29, 2024

Regeneron and Mammoth team up to develop gene editing therapies

Share this article The CRISPR-based gene editing therapies will target multiple tissues and cell types. Credit: Anusorn Nakdee via Shutterstock. Regeneron Pharmaceuticals has collaborated with

April 26, 2024

Age-based comparison of TAVR outcomes in Vietnamese patients with aortic stenosis

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The increasing number of elderly patients with severe aortic valve stenosis undergoing transcatheter aortic

March 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.